Single molecule biochips

Acute Traumatic Coagulopathy, a term first coined by Queen Mary’s Karim Brohi in 2003, occurs when traumatic bleeding leads to abnormal blood clotting. The result is more severe bleeding, organ failure, and death.

Tests for coagulopathy take too long to be useful in a trauma centre where every second counts.

Queen Mary scientists led by Prof Matteo Palma are developing life-saving portable nanoscale biochips which can diagnose patients in real time so clinicians can intervene immediately to improve blood clotting and prevent fatal bleeding.

We envisage this technology being invaluable for emergency departments, air ambulances, operating theatres, intensive care units, and within the military.

We’re looking for commercial partners and investors to help us develop the technology further.